(LOGC) Logicbio Therapeutics complete technical analysis [charts+indicators] | Buy/Sell Logicbio Therapeutics | (LOGC) share price targets
Complete technical analysis of Logicbio Therapeutics (LOGC) by charts plus indicators, forecast predictions and share price targets for Logicbio Therapeutics (LOGC)
Logicbio Therapeutics trades in USA in Health Care sector.
Showing technical analysis as on 2024-09-11 View latest technical analysis
10 day averaged volume of Logicbio Therapeutics is 199459
| Date | Daily Closing Price | Open | High | Low | Volume |
| 11 Wed Sep 2024 | 5.35 | 5.32 | 5.42 | 5.26 | 0.552 times |
| 10 Tue Sep 2024 | 5.35 | 5.32 | 5.35 | 5.16 | 0.679 times |
| 09 Mon Sep 2024 | 5.32 | 5.20 | 5.40 | 5.20 | 1.469 times |
| 06 Fri Sep 2024 | 5.19 | 5.20 | 5.23 | 5.13 | 0.904 times |
| 05 Thu Sep 2024 | 5.21 | 5.20 | 5.33 | 5.19 | 0.973 times |
| 04 Wed Sep 2024 | 5.18 | 5.16 | 5.26 | 5.15 | 1.074 times |
| 03 Tue Sep 2024 | 5.20 | 5.31 | 5.37 | 5.12 | 1.975 times |
| 30 Fri Aug 2024 | 5.40 | 5.42 | 5.46 | 5.37 | 0.603 times |
| 30 Fri Aug 2024 | 5.40 | 5.42 | 5.46 | 5.37 | 0.605 times |
| 29 Thu Aug 2024 | 5.43 | 5.46 | 5.52 | 5.37 | 0.9 times |
My analysis of stock is bearish for shortterm, and stock might move down till 5.3 or till 5.1. Use a stoploss of 5.39 and if the stock hits stoploss, then it can shoot up till 5.5
Share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Target | 4.92 |
| Downside Target | 5.12 |
| Downside Target | 5.31 |
| Upside Target | 5.42 |
| Upside Target | 5.46 |
| Upside Target | 5.52 |
| Upside Target | 5.61 |
| Upside Target | 5.85 |
| Upside Target | 6.05 |
| Upside Target | 6.29 |
Intraday share price targets for Logicbio Therapeutics (LOGC)
| Target Type | Value |
| Downside Intraday Target | 5.2 |
| Downside Intraday Target | 5.05 |
| Upside Intraday Target | 5.46 |
| Upside Intraday Target | 5.57 |
| Downside Intraday Target | 5.31 |
Weekly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 11 Wed Sep 2024 | 5.35 | 5.20 | 5.42 | 5.16 | 0.548 times |
| 06 Fri Sep 2024 | 5.19 | 5.31 | 5.37 | 5.12 | 8.166 times |
| 30 Fri Aug 2024 | 5.40 | 5.42 | 5.46 | 5.37 | 0.158 times |
| 30 Fri Aug 2024 | 5.40 | 5.45 | 5.52 | 5.34 | 0.557 times |
| 23 Fri Aug 2024 | 5.48 | 5.48 | 5.61 | 5.32 | 1.094 times |
Price has moved up this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Logicbio Therapeutics (LOGC)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 11 Wed Sep 2024 | 5.35 | 5.31 | 5.42 | 5.12 | 0.228 times |
| 30 Fri Aug 2024 | 5.40 | 5.44 | 5.61 | 4.92 | 1.067 times |
| 31 Wed Jul 2024 | 5.40 | 5.59 | 6.29 | 5.34 | 0.604 times |
| 28 Fri Jun 2024 | 5.71 | 5.38 | 6.05 | 5.31 | 1.706 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Logicbio Therapeutics (LOGC)
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Logicbio Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Logicbio Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.28 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but trend is highly volatile. A longer time period analysis might give a better idea of the trend.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Logicbio Therapeutics ( (LOGC) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Logicbio Therapeutics stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a BUY signal for Logicbio Therapeutics in short term but the buy signal is initial and weak.
MACD line is moving upwards which means that SELL signal is weakening, and buying is picking up momentum.
Logicbio Therapeutics Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bulls are getting stronger in this stock.
Ichimoku cloud is of red color and prices are in or above the red cloud Prices appear to be coming down
CCI has generated a buy signal for Logicbio Therapeutics in short term and BUY signal is strong.
RSI is generating a BUY signal in short term but buying is losing momentum.
MRSI is in positive zone. This is a BUY zone
Stock of Logicbio Therapeutics is picking up buying momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 5.28 and Logicbio Therapeutics (LOGC) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Logicbio Therapeutics (LOGC) stock. Volume based technical analysis of Logicbio Therapeutics (LOGC) stock is negative.
Logicbio Therapeutics Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.